We are live on ! Find out more
ACM

AIHC Capital Management Portfolio holdings

AUM $104M
This Fund
S&P 500
This Quarter Est. Return
+43.59%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$104M
AUM Growth
-$15.4M
Cap. Flow
-$65.1M
Cap. Flow %
-62.47%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
2
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
ORIC icon
Oric Pharmaceuticals
ORIC
+$12.4M
2
NBP
NovaBridge Biosciences American Depositary Shares
NBP
+$1.25M

Top Sells

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$76.8M
2
COGT icon
Cogent Biosciences
COGT
+$1.98M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$44.6B
$56.8M 54.46%
303,133
-525,841
-63% -$76.8M
ORIC icon
2
Oric Pharmaceuticals
ORIC
$1.37B
$41.5M 39.77%
3,828,460
+1,368,909
+56% +$12.4M
NBP
3
NovaBridge Biosciences American Depositary Shares
NBP
$213M
$5.61M 5.38%
2,878,033
+615,100
+27% +$1.25M
KRRO icon
4
Korro Bio
KRRO
$190M
$399K 0.38%
30,265
– –
COGT icon
5
Cogent Biosciences
COGT
$6.02B
– –
-51,402
Closed -$1.98M

Similar funds

TPW
TOP Private Wealth Glastonbury, Connecticut $104M AUM
TOTUOP
Trustees of The University of Pennsylvania Philaldelphia, Pennsylvania $104M AUM
XFP
Xena Financial Planning Portland, Oregon $104M AUM
SFG
Strategic Financial Group Grand Haven, Michigan $104M AUM
JRSI
Jeter Robert S II $104M AUM
VA
Verdad Advisers Boston, Massachusetts $104M AUM
IAP
Indie Asset Partners Carmel, Indiana $104M AUM 31.76% 1-Year Est. Return
GAM
Gritstone Asset Management Bethesda, Maryland $104M AUM 6.03% 1-Year Est. Return

AIHC Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, AIHC Capital Management held 5 positions worth $104M, down 13% from $120M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

AIHC Capital Management withdrew a net $65.1M in Q2 2026, closing 1 position and reducing 1 holding. Its most notable exit was Cogent Biosciences, an estimated $1.98M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, AIHC Capital Management added an estimated $12.4M to Oric Pharmaceuticals.

  • AIHC Capital Management added most to Oric Pharmaceuticals in Q2 2026, an estimated $12.4M increase.
  • AIHC Capital Management's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $76.8M.
  • AIHC Capital Management fully exited Cogent Biosciences in Q2 2026, selling an estimated $1.98M.
  • AIHC Capital Management's ten largest holdings make up 100% of its $104M portfolio in Q2 2026.
  • AIHC Capital Management opened 0 new positions and closed 1 in Q2 2026.
  • AIHC Capital Management's portfolio value fell 13% quarter-over-quarter to $104M.

Based on AIHC Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.